Regeneron Pharmaceuticals Inc (REGN)

591.13
-6.49(-1.09%)
After Hours
584.50
-6.63(-1.12%)
- Real-time Data
  • Volume:
    680,742
  • Day's Range:
    583.05 - 598.67
  • 52 wk Range:
    538.01 - 747.42

REGN Overview

Prev. Close
597.62
Day's Range
583.05-598.67
Revenue
16.51B
Open
594.93
52 wk Range
538.01-747.42
EPS
70.56
Volume
680,742
Market Cap
63.69B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
700,302
P/E Ratio
8.47
Beta
0.3
1-Year Change
5.83%
Shares Outstanding
107,746,194
Next Earnings Date
Aug 04, 2022
What is your sentiment on Regeneron Pharma?
or
Market is currently closed. Voting is open during market hours.

Regeneron Pharmaceuticals Inc News

Regeneron Pharmaceuticals Inc Analysis

Regeneron Pharmaceuticals Inc Company Profile

Regeneron Pharmaceuticals Inc Company Profile

Employees
9766

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellNeutralBuy
SummaryStrong SellStrong SellStrong SellSellBuy